Increased EGFR activity is characteristic of a number of tumors such as glioblastoma, non-small cell lung cancer (NSCL), head and neck squamous cell carcinoma (HNSCC), and breast, colon, ovarian, prostate, or pancreatic cancer [7,12,13]. Here, EGFR is linked to glioblastoma.